Health
Hard choices emerge as link between AstraZeneca vaccine and rare clotting disorder becomes clearer – Science Magazine
Some scientists suggest halving the dose might reduce risks and help protect more people from COVID-19
By Kai Kupferschmidt, Gretchen VogelApr. 11, 2021 , 7:15 AM
Sciences COVID-19 reporting is supported by the Heising-Simons Foundation.
What was a worrisome suspicion four weeks ago is now widely accepted: The AstraZeneca COVID-19 vaccine can, in very rare cases, cause a disorder characterized by dangerous blood clots and low platelet counts. In Europe, at least 222 suspected cases have been reported among 34 million who have received their first dose of the vaccine. More than 30 have died.
Causality…
-
Business15 hours agoWarning! These ASX 200 shares were just downgraded
-
Business13 hours ago2 monthly payers you’ll want to own in 2025 and beyond
-
General24 hours agoTelco Exetel fined $694K after scammers bypass verification processes, access bank accounts
-
General23 hours agoSergio Perez and Valtteri Bottas to return to Formula 1 with Cadillac